Related Experiment Video

Updated: Jul 17, 2025

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.3K

Patent profile for the approved and in clinical trials Mpox vaccines

Irene von der Weid1, Cristina d'Urso de Souza Mendes1, Paula C Fonseca2

  • 1National Institute of Industrial Property, Division of Studies & Projects, Rio de Janeiro, Rio de Janeiro, 20090-910, Brazil.

Pharmaceutical Patent Analyst
|September 6, 2023
PubMed

Insights

This study analyzed smallpox vaccine patents for mpox (monkeypox) prevention. Few patents exist, with one in litigation, highlighting a need for mpox-specific vaccine development and patent monitoring.

Area of Science:

  • Virology
  • Immunology
  • Intellectual Property Law

Background:

  • Mpox (monkeypox) has spread globally since May 2022, causing significant public health concern.
  • Existing smallpox vaccines offer cross-protection against mpox, but specific mpox vaccines are lacking.
  • No comprehensive analysis of the patent landscape for mpox vaccines has been published.

Purpose of the Study:

  • To identify the patent status of smallpox vaccines currently applied for mpox (monkeypox) prevention.
  • To analyze the existing patent portfolios and potential legal challenges for these vaccines.
  • To provide insights into the intellectual property landscape for mpox prophylaxis.

Main Methods:

  • Systematic search for patents related to smallpox vaccines with potential mpox application.
  • Analysis of retrieved patents, including patent holder, geographical coverage, and litigation status.
  • Review of scientific literature for publications on mpox vaccine development and intellectual property.

Main Results:

  • Ten smallpox vaccines with potential mpox application were identified.
  • Only a limited number of these vaccines possess established patent portfolios.
  • One vaccine is currently involved in patent litigation proceedings across three continents.
  • No patents for vaccines specifically developed for mpox were found.

Conclusions:

  • The current patent landscape for mpox vaccines is underdeveloped, with limited intellectual property protection.
  • The ongoing patent litigation highlights complexities in vaccine intellectual property.
  • Further technological monitoring and research are crucial for developing specific mpox vaccines and securing future prophylaxis.
Keywords:
Mpoxpatentsmallpoxvaccines

More Related Videos

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

1.8K
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

1.8K

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.8K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
400
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
886
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147